Skip to main content
Fig. 5 | BMC Pulmonary Medicine

Fig. 5

From: Analyzing lung cancer risks in patients with impaired pulmonary function through characterization of gut microbiome and metabolites

Fig. 5

Differential metabolites and enriched signalling pathways. (A) 69 differential metabolites were filtered by Kruskal-Wallis H test. (B) KEGG pathway enrichment analysis. (C) Important metabolites displayed on variable importance in projection (VIP) plot obtained from OPLS-DA. *P < 0.05, **P < 0.01, ***P < 0.001

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us